Hospital Universitario Pío del Río Hortega -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide

    Leukemia and Lymphoma, Vol. 50, Núm. 8, pp. 1283-1289